Platelet-Rich Plasma and Shockwave Therapy Prove Effective for Interstitial Cystitis

A recent study published in Frontiers in Bioengineering and Biotechnology demonstrates that combining platelet-rich plasma (PRP) with low-intensity extracorporeal shock wave therapy (LI-ESWT) offers therapeutic benefits for patients with interstitial cystitis/bladder pain syndrome. This dual-treatment approach represents a promising non-invasive option for managing this chronic condition, which causes bladder and pelvic pain. The findings provide hope for IC/BPS patients who have limited treatment options and often experience significant quality-of-life impacts. These innovative therapies work together to potentially reduce inflammation and promote healing in bladder tissue.